EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document 91997E002855
WRITTEN QUESTION No. 2855/97 by Ria OOMEN-RUIJTEN , Raphaël CHANTERIE to the Commission. Homeopathic medicinal products
WRITTEN QUESTION No. 2855/97 by Ria OOMEN-RUIJTEN , Raphaël CHANTERIE to the Commission. Homeopathic medicinal products
WRITTEN QUESTION No. 2855/97 by Ria OOMEN-RUIJTEN , Raphaël CHANTERIE to the Commission. Homeopathic medicinal products
OJ C 102, 3.4.1998, p. 138
(ES, DA, DE, EL, EN, FR, IT, NL, PT, FI, SV)
WRITTEN QUESTION No. 2855/97 by Ria OOMEN-RUIJTEN , Raphaël CHANTERIE to the Commission. Homeopathic medicinal products
Official Journal C 102 , 03/04/1998 P. 0138
WRITTEN QUESTION E-2855/97 by Ria Oomen-Ruijten (PPE) and Raphaël Chanterie (PPE) to the Commission (11 September 1997) Subject: Homeopathic medicinal products 1. What is the position regarding evaluation of EC directives 92/73 ((OJ L 297, 13.10.1992, p. 8. )) and 92/74 ((OJ L 297, 13.10.1992, p. 12. )) on the registering of homeopathic medicinal products? 2. Is it true that the aim of these objectives - the harmonization of homeopathic medicinal products in the EU - has not been achieved because of failure to implement them properly or consistently in the Member States? 3. Is an evaluation report available and, if so, will the Commission forward it to Parliament? 4. On the basis of the evaluation will the Commission propose a change in legislation and, if so, when? 5. What are the main points in respect of which legislation might need to be changed? Answer given by Mr Bangemann on behalf of the Commission (29 September 1997) On 14 July 1997 the Commission forwarded to the Parliament and Council its report on the application of Directives 92/73/EEC and 92/74/EEC on homeopathic medicinal products ((COM(97) 362 final. )). All questions raised by the Honourable Members are answered in this report which, in its conclusions, also asks the Parliament and Council to express their view on particular problems raised in the report and to consider whether certain amendments to the directives on homeopathic medicinal products should be envisaged.